CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Ciliopathies
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Hyperammonemia
|
0.110 |
Biomarker
|
phenotype |
HPO |
|
|
|
Failure to Thrive
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hypoglycemia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Icterus
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Liver Failure
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Prothrombin time increased
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cirrhosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Rapidly progressive
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Elevated hepatic transaminase
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Mitral Valve Stenosis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Furthermore, no differences in BAR mRNA expression were observed between myocardium subjected to mitral stenosis as compared to normal myocardium.
|
1666018 |
1991 |
Rheumatic mitral stenosis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Furthermore, no differences in BAR mRNA expression were observed between myocardium subjected to mitral stenosis as compared to normal myocardium.
|
1666018 |
1991 |
Fragile X Syndrome
|
0.020 |
Biomarker
|
disease |
BEFREE |
The FXR proteins are associated with 60S ribosomal subunits even in cells that lack FMR1 and that are derived from a fragile X syndrome patient, indicating that FMR1 is not required for this association.
|
8668200 |
1996 |
Obesity
|
0.270 |
GeneticVariation
|
disease |
BEFREE |
We examined the prevalence of the two 3-BAR alleles in Germany and looked for associations between 3-BAR genotype and metabolic disorders (obesity and type 2 diabetes mellitus).
|
9709965 |
1998 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
We examined the prevalence of the two 3-BAR alleles in Germany and looked for associations between 3-BAR genotype and metabolic disorders (obesity and type 2 diabetes mellitus).
|
9709965 |
1998 |
Metabolic Diseases
|
0.050 |
GeneticVariation
|
group |
BEFREE |
We examined the prevalence of the two 3-BAR alleles in Germany and looked for associations between 3-BAR genotype and metabolic disorders (obesity and type 2 diabetes mellitus).
|
9709965 |
1998 |
Liver carcinoma
|
0.530 |
Biomarker
|
disease |
MGD |
Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.
|
11030617 |
2000 |
Liver neoplasms
|
0.520 |
Biomarker
|
group |
MGD |
Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.
|
11030617 |
2000 |
Malignant neoplasm of liver
|
0.520 |
Biomarker
|
disease |
MGD |
Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.
|
11030617 |
2000 |
Obesity
|
0.270 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, the present study failed to demonstrate an additive or synergistic effect of the Trp/Arg64 variant of the BAR gene and the -3826 A-->G variant of the UCP1 gene on the development of obesity and insulin resistance among randomly recruited Danish Caucasian subjects.
|
10999801 |
2000 |
Hepatoblastoma
|
0.210 |
Biomarker
|
disease |
MGD |
Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.
|
11030617 |
2000 |
Hepatoblastoma Caused By Somatic Mutation
|
0.200 |
Biomarker
|
disease |
MGD |
Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.
|
11030617 |
2000 |